← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
51	51 ProKidney PROK $307M	67	-14	-17%	$191M
52	52 Solid Biosciences SLDB $586M	67	-10	-13%	$39.5M
53	AKUS 53 DELISTED Akouos Inc AKUS	66	-8	-11%	$165M
54	54 Celularity CELU $42.5M	66	+28	+74%	$105M
55	55 Fortress Biotech FBIO $63.4M	66	-13	-16%	$25.9M
56	56 Neurogene NGNE $444M	63	-18	-22%	$21.4M
57	57 Taysha Gene Therapies TSHA $1.14B	59	-12	-17%	$54.7M
58	GMDA 58 DELISTED Gamida Cell Ltd. Ordinary Shares GMDA	57	-2	-3%	$25.9M
59	59 Century Therapeutics IPSC $250M	56	+4	+8%	$183M
60	60 DELISTED Poseida Therapeutics, Inc. Common Stock PSTX	56	-8	-13%	$58.1M
61	61 Cabaletta Bio CABA $275M	55	-7	-11%	$17.8M
62	SQZ 62 DELISTED SQZ Biotechnologies Company SQZ	53	0	0%	$47.1M
63	63 DELISTED CERo Therapeutics CERO	52	+6	+13%	$145M
64	64 Lunai Bioworks LNAI $4.05M	51	+8	+19%	$7.64M
65	ORTX 65 DELISTED Orchard Therapeutics plc American Depositary Shares ORTX	50	-12	-19%	$30.2M
66	66 Tenaya Therapeutics TNYA $87.6M	50	0	0%	$209M
67	67 Immatics IMTX $1.07B	49	+2	+4%	$187M
68	68 DELISTED BRAINSTORM CELL THERAPUTC BCLI	48	+9	+23%	$11M
69	69 Marker Therapeutics MRKR $14.8M	48	-1	-2%	$7.36M
70	AGTC 70 DELISTED Applied Genetic Technologies Corporation AGTC	47	-6	-11%	$8.53M
71	LOGC 71 DELISTED LogicBio Therapeutics, Inc. Common Stock LOGC	47	+1	+2%	$3.88M
72	72 DELISTED NKGen Biotech, Inc. Common Stock NKGN	47	+3	+7%	$124M
73	73 Cellectis CLLS $113M	44	-6	-12%	$30.6M
74	74 Abeona Therapeutics ABEO $249M	42	-12	-22%	$4.68M
75	DBTX 75 DELISTED Decibel Therapeutics, Inc. Common Stock DBTX	42	+3	+8%	$75.2M